IL95158A0 - Pharmaceutical composition for oral administration containing n-acetyl-cysteine - Google Patents

Pharmaceutical composition for oral administration containing n-acetyl-cysteine

Info

Publication number
IL95158A0
IL95158A0 IL95158A IL9515890A IL95158A0 IL 95158 A0 IL95158 A0 IL 95158A0 IL 95158 A IL95158 A IL 95158A IL 9515890 A IL9515890 A IL 9515890A IL 95158 A0 IL95158 A0 IL 95158A0
Authority
IL
Israel
Prior art keywords
cysteine
acetyl
pharmaceutical composition
oral administration
administration containing
Prior art date
Application number
IL95158A
Other languages
English (en)
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of IL95158A0 publication Critical patent/IL95158A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL95158A 1989-07-27 1990-07-23 Pharmaceutical composition for oral administration containing n-acetyl-cysteine IL95158A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921339A IT1231012B (it) 1989-07-27 1989-07-27 Composizione farmaceutica per uso orale contenente nac.

Publications (1)

Publication Number Publication Date
IL95158A0 true IL95158A0 (en) 1991-06-10

Family

ID=11180335

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95158A IL95158A0 (en) 1989-07-27 1990-07-23 Pharmaceutical composition for oral administration containing n-acetyl-cysteine

Country Status (20)

Country Link
US (1) US5080906A (da)
JP (1) JPH0399012A (da)
KR (1) KR910002438A (da)
AU (1) AU625925B2 (da)
BE (1) BE1003188A4 (da)
CA (1) CA2021808A1 (da)
CH (1) CH680190A5 (da)
DE (1) DE4023774A1 (da)
DK (1) DK177890A (da)
FI (1) FI903759A0 (da)
FR (1) FR2650503B1 (da)
GB (1) GB2234171B (da)
GR (1) GR900100569A (da)
IE (1) IE902627A1 (da)
IL (1) IL95158A0 (da)
IT (1) IT1231012B (da)
NL (1) NL9001714A (da)
NZ (1) NZ234647A (da)
SE (1) SE9002500L (da)
ZA (1) ZA905861B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
IT1256616B (it) * 1992-12-02 1995-12-12 Zambon Spa Sciroppo contenente n-acetil-cisteina
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
BE1007926A3 (fr) * 1994-01-31 1995-11-21 Zambon Int Pharma Composition pharmaceutique contenant de la n-acetyl-cysteine.
CA2276183C (en) 1996-12-31 2009-06-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
FR2803720B1 (fr) * 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6114387A (en) * 2000-02-16 2000-09-05 Cutler; Paul Pharmaceutical composition for oral administration of chelating agents
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
US20030162732A1 (en) * 2001-07-05 2003-08-28 Astion Development A/S Combination of aminosugars and cysteine or cysteine derivatives
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
ITMI20021881A1 (it) * 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
US20050008699A1 (en) * 2003-07-11 2005-01-13 Fred Wehling Effervescent glucosamine composition
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
KR20050104152A (ko) * 2004-04-28 2005-11-02 최승호 경구용 약물의 흡수를 증진하는 약제학적 조성물
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
TR200900882A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
PL3554491T3 (pl) * 2016-12-15 2023-07-17 Zambon S.P.A. N-acetylocysteina do stosowania jako środek antybakteryjny
WO2020021324A1 (en) * 2018-07-27 2020-01-30 I.C.F. Srl Compositions for the prevention and treatment of cutaneous affections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
US4894225A (en) * 1987-03-02 1990-01-16 Cetus Corporation Combination therapy using antitumor immunotoxins with tumor necrosis factor
JPS63290824A (ja) * 1987-05-22 1988-11-28 Sumitomo Chem Co Ltd ウイルス感染症治療剤
IT1217445B (it) * 1988-04-29 1990-03-22 Altergon Sa Composizione farmaceutiche orosolubili contenti acetilcisteina

Also Published As

Publication number Publication date
GB2234171B (en) 1993-11-10
SE9002500L (sv) 1991-01-28
ZA905861B (en) 1991-07-31
DK177890D0 (da) 1990-07-26
AU625925B2 (en) 1992-07-16
DE4023774A1 (de) 1991-01-31
CH680190A5 (da) 1992-07-15
GB9016256D0 (en) 1990-09-12
CA2021808A1 (en) 1991-01-28
IE902627A1 (en) 1991-02-27
FR2650503A1 (fr) 1991-02-08
IT1231012B (it) 1991-11-08
US5080906A (en) 1992-01-14
BE1003188A4 (fr) 1992-01-07
GB2234171A (en) 1991-01-30
FI903759A0 (fi) 1990-07-27
JPH0399012A (ja) 1991-04-24
SE9002500D0 (sv) 1990-07-26
AU5993590A (en) 1991-01-31
NZ234647A (en) 1992-02-25
KR910002438A (ko) 1991-02-25
NL9001714A (nl) 1991-02-18
IT8921339A0 (it) 1989-07-27
FR2650503B1 (fr) 1992-05-29
GR900100569A (el) 1991-12-10
DK177890A (da) 1991-01-28

Similar Documents

Publication Publication Date Title
IL82911A (en) Pharmaceutical composition comprising omeprazole for oral use
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
EP0202051A3 (en) Therapeutic compositions for oral administration
AU5157590A (en) Pharmaceutical compositions for oral administration
IL83349A (en) Stable pharmaceutical composition comprising cimetidine polymorph b suitable for oral administration
IL92054A0 (en) Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof,their preparation and pharmaceutical compositions containing them
ZA894344B (en) Stable pharmaceutical composition
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
IL87943A0 (en) Pharmaceutical compositions for piperidinoalkanol-decongestant combination
IL87921A0 (en) Pharmaceutical composition for piperidinoalkanol derivatives
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
IL86437A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
GB8814615D0 (en) 8-acrylaminoergoline its preparation & pharmaceutical compositions containing it
IL95105A0 (en) Oral pharmaceutical compositions having controlled bioavailability
IL93270A0 (en) Pharmaceutical compositions for oral administration
EG19689A (en) New pharmaceutical preparation for oral use
AU647444B2 (en) Oxipurinol salt composition for oral administration for treating hyperurecemia
IE900393L (en) Pharmaceutical compositions for oral administration
IE861385L (en) Oral pharmaceutical composition
AU601974C (en) New pharmaceutical preparation for oral use
GB8605037D0 (en) Oral pharmaceutical compositions
IE893646L (en) Pharmaceutical compositions for topical administration
ZA887413B (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU5273993A (en) Oral pharmaceutical administration device